ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 982,80
-1,05%
DAX
17 932,17
-1,10%
Brent Oil
86,335
-1,09%
Bitcoin
60 183,17
-5,73%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Rocket Pharmaceuticals Inc (RCKT)

  7. Rocket Pharmaceuticals Inc (RCKT) Actualités

RCKT Rocket Pharmaceuticals Inc

21,83
-0,02 (-0,09%)
Dernière mise à jour : 20:16:04
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Rocket Pharmaceuticals Inc RCKT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,02 -0,09% 21,83 20:16:04
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
21,57 21,44 22,18 21,85
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/4/202412:00BWRocket Pharmaceuticals Announces European Medicines Agency..
26/3/202421:01BWRocket Pharmaceuticals Announces Appointment of Aaron Ondrey..
05/3/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202421:54EDGAR2Form 144 - Report of proposed sale of securities
29/2/202420:59EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:37EDGAR2Form 8-K - Current report
26/2/202422:01BWRocket Pharmaceuticals Reports Fourth Quarter and Full Year..
22/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:28EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
16/2/202422:37EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:31EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:26EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:22EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:37EDGAR2Form 8-K - Current report
13/2/202413:00BWRocket Pharmaceuticals Announces Update on FDA Review..
29/1/202421:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202421:16EDGAR2Form 144 - Report of proposed sale of securities
02/1/202422:01BWRocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan..
13/12/202322:05EDGAR2Form 8-K - Current report
13/12/202302:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202302:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/12/202313:00BWRocket Pharmaceuticals Appoints R. Keith Woods to Board of..
17/11/202301:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202301:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202301:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202300:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202321:28EDGAR2Form 144 - Report of proposed sale of securities
16/11/202321:21EDGAR2Form 144 - Report of proposed sale of securities
16/11/202321:21EDGAR2Form 144 - Report of proposed sale of securities
07/11/202322:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:04BWRocket Pharmaceuticals Reports Third Quarter 2023 Financial..
25/10/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202321:19EDGAR2Form 144 - Report of proposed sale of securities
19/10/202313:00BWRocket Pharmaceuticals Announces Presentations Highlighting..
10/10/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202303:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:05EDGAR2Form 8-K - Current report
02/10/202313:00BWRocket Pharmaceuticals Announces FDA Acceptance of Biologics..
26/9/202322:01BWRocket Pharmaceuticals to Participate in the Chardan 7th..
20/9/202322:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

Dernières Valeurs Consultées

NASDAQ
RCKT
Rocket Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés